The FDA urges manufacturers to revise labeling of transmucosal buprenorphine products to ease access to higher doses because ...

In the face of an opioid overdose crisis, President Biden oversaw a historic shift toward harm reduction for addiction.

The Drug Enforcement Administration (DEA) and the U.S. Department of Health & Human Services (HHS) just finalized their March 2023 proposed ...

HHS and the Drug Enforcement Administration have finalized a rule that expands telemedicine prescribing of buprenorphine for opioid use disorder, while also proposing a new special registration ...

The Drug Enforcement Administration proposed a special registration process for remote prescribing of controlled substances ...

Buprenorphine treatment with medical counseling helps many patients achieve partial response, if not near-total abstinence from opioid use disorder.

Buprenorphine dispensing increased among adolescents and decreased among young adults between 2020 and 2023, according to a research letter published online Dec. 23 in the Journal of the American ...

THURSDAY, Dec. 26, 2024 (HealthDay News) — Buprenorphine dispensing increased among adolescents and decreased among young ...

A clinical algorithm and implementation evaluation protocol for sublingual and injectable buprenorphine treatment of opioid ...

The Department of Health and Human Services and Drug Enforcement Administration published a series of rules Jan. 15 related ...